Cecilia C. Welch - 02 Sep 2025 Form 4 Insider Report for BIO KEY INTERNATIONAL INC (BKYI)

Reporting relationship: Chief Financial Officer
Issuer ticker: BKYI
Reported as of: 02 Sep 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Sep 2025, 17:19:19 UTC
Prior SEC filing: 02 Aug 2024
Source filing: View source filing
Reporting owner signature: /s/ Cecilia C. Welch

Filing notes and source

Key filing fact

Cecilia C. Welch filed Form 4 for BIO KEY INTERNATIONAL INC (BKYI) on 03 Sep 2025.

Key facts

This page summarizes Cecilia C. Welch's Form 4 filing for BIO KEY INTERNATIONAL INC (BKYI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Sep 2025, 17:19.

Change

Previous filing in this sequence was filed on 02 Aug 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001479589 Primary reporting owner

Welch Cecilia C

Relationship: Chief Financial Officer
Address: C/O BIO-KEY INTERNATIONAL, INC., 101 CRAWFORDS CORNER RD, SUITE 4116, HOLMDEL
Signature: /s/ Cecilia C. Welch
Signature date: 03 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BKYI transaction

Common Stock

Award

Transaction value: $0
Shares: +35,000
Change %: +143%
Price: $0.000000
Shares after: 59,396
Date: 02 Sep 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, as amended, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date.

Footnote F2

Holdings do not include options to purchase 174 shares.